Sight Sciences (SGHT) Gains from Sales and Divestitures (2022 - 2026)
Sight Sciences (SGHT) recorded quarterly Gains from Sales and Divestitures of $471069.0 in Q1 2026, down 71.59% quarter-over-quarter from $1.7 million in Q4 2025, and up 16.72% on a YoY basis from $403584.0 in Q1 2025.
Sight Sciences (SGHT) Gains from Sales and Divestitures (2022 - 2026) Analysis & Trends
Sight Sciences' Gains from Sales and Divestitures history runs 5 years deep, the most recent figure standing at $471069.0 for Q1 2026.
- In Q1 2026, Gains from Sales and Divestitures rose 16.72% year-over-year to $471069.0; the TTM figure through Mar 2026 stood at $471069.0 (up 16.72% YoY), while the FY2025 annual figure was $1.7 million, up 33.02% from the prior year.
- Gains from Sales and Divestitures was $471069.0 for Q1 2026 at Sight Sciences, down from $1.7 million in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $1.7 million in Q4 2025 to a low of $11028.0 in Q4 2022.
- Historically, Gains from Sales and Divestitures has averaged $779013.4 across 5 years, with a median of $874208.0 in 2025.
- The sharpest annual moves came in 2023 and 2026: Gains from Sales and Divestitures jumped 2109.51% in 2023, then gained 16.72% in 2026.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $11028.0 in 2022, then surged by 2109.51% to $243665.0 in 2023, then jumped by 411.64% to $1.2 million in 2024, then soared by 33.02% to $1.7 million in 2025, then sank by 71.59% to $471069.0 in 2026.
- The last three Gains from Sales and Divestitures figures came in at $471069.0 (Q1 2026), $1.7 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Sight Sciences | 274.57 Mn | 189.61 Mn | 16.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 471,069.00 |
| Mar 31, 2026 | 471,069.00 |
| Dec 31, 2025 | 1.66 Mn |
| Dec 31, 2025 | 1.66 Mn |
| Sep 30, 2025 | 1.22 Mn |
| Sep 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | 874,208.00 |
| Jun 30, 2025 | 874,208.00 |
| Mar 31, 2025 | 403,584.00 |
| Mar 31, 2025 | 403,584.00 |
| Dec 31, 2024 | 1.25 Mn |
| Dec 31, 2024 | 1.25 Mn |
| Sep 30, 2024 | 883,206.00 |
| Sep 30, 2024 | 883,206.00 |
| Dec 31, 2023 | 243,665.00 |
| Dec 31, 2023 | 243,665.00 |
| Dec 31, 2022 | 11,028.00 |
| Dec 31, 2022 | 11,028.00 |